BAKER BROS. ADVISORS LP – Crinetics Pharmaceuticals, Inc. Transaction History
BAKER BROS. ADVISORS LP portfolio value:
$14.44M
portfolio value
BAKER BROS. ADVISORS LP quarter portfolio value change:
+5.31%
quarter
Crinetics Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -11.09% | -91.76K shares | -984K | $19.64 | 735.71K |
| Q2 2022 | share | 0.00% | 0 shares | -2.73M | $18.65 | 827.48K | |
| Q1 2022 | share | 0.00% | 0 shares | -5.34M | $21.95 | 827.48K | |
| Q4 2021 | share | Decrease | -10.12% | -93.17K shares | 4.12M | $28.03 | 827.48K |
| Q3 2021 | share | 0.00% | 0 shares | 2.02M | $21.05 | 920.65K | |
| Q2 2021 | share | Increase | +49.33% | 304.13K shares | 7.93M | $18.85 | 920.65K |
| Q1 2021 | share | 0.00% | 0 shares | 721K | $15.28 | 616.52K | |
| Q4 2020 | share | Increase | +103.93% | 314.2K shares | 3.96M | $14.11 | 616.52K |
| Q3 2020 | share | Decrease | -4.89% | -15.53K shares | -832K | $15.67 | 302.32K |
| Q2 2020 | share | Increase | +81.63% | 142.85K shares | 2.99M | $17.52 | 317.85K |
| Q1 2020 | share | 0.00% | 0 shares | -1.81M | $14.7 | 175K | |
| Q4 2019 | share | 0.00% | 0 shares | 1.75M | $25.09 | 175K | |
| Q3 2019 | share | Increase | +31.59% | 42.01K shares | -693K | $15.04 | 175K |
| Q2 2019 | share | Increase | +1.32% | 1.73K shares | 338K | $25 | 132.98K |
| Q1 2019 | share | 0.00% | 0 shares | -949K | $22.76 | 131.25K | |
| Q4 2018 | share | 0.00% | 0 shares | 176K | $29.99 | 131.25K | |
| Q3 2018 | share | Increase | 0.00% | 131.25K shares | 3.76M | $28.65 | 131.25K |